Global Gene has partnered with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), Department of Radiation Oncology, to research into cancers in South Asian and Indian populations.

The partnership with OSUCCC-James will help support the company’s aim of focusing on personalised healthcare data at a global level.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Under the collaboration, the partners will molecularly profile tumours using the latest and advanced technology deployed in the laboratory of OSUCCC-James Department of Radiation Oncology chairman Dr Arnab Chakravarti.

Chakravarti said: “To help fight cancer, one has to build a representative and unique perspective that leads to novel insights.

“To help fight cancer, one has to build a representative and unique perspective that leads to novel insights.”

“India and South East Asia have different manifestations of cancer compared to cancers that are considered rare in the West. We aim to study why.”

As part of the deal, Global Gene will provide access to longitudinal, genomics data, insights and analytics for unexplored patient populations in South Asia.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Global Gene chairman and chief executive officer Sumit Jamuar said: “Using a high-throughput approach to understand the drivers for a variety of rare and common cancers will allow us to truly develop insights that will lead to personalised medicine for patients.

“By working with under-represented populations, both organisations can fill in key gaps needed for discovery with global applications, while simultaneously helping people in South Asian and Indian populations.”